Tag archive for ‘SARS-CoV-2 virus’
DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG - 2DG inhibits SARS-COV-2-growth and Cyto-Pathic Effect.
By businessnewstoday On Saturday, May 8th, 2021
0 Comments

DCGI gives emergency use approval for DRDO’s anti-COVID drug 2-DG

The Drugs Controller General of India (DCGI) has given emergency use approval for 2-deoxy-D-glucose (2-DG) of Defence Research and Development Organisation (DRDO) for the treatment of Covid-19. The DRDO drug has More...

CORAT Therapeutics begins COR-101 clinical trial in hospitalized Covid patients
By businessnewstoday On Monday, April 26th, 2021
0 Comments

CORAT begins COR-101 clinical trial in hospitalized Covid patients

CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101 for the treatment of hospitalized Covid-19 patients. According to the German pharma company, COR-101 can More...

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU
By Soujanya Ravi On Saturday, March 27th, 2021
0 Comments

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. The Janssen More...

Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205
By businessnewstoday On Tuesday, March 16th, 2021
0 Comments

Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205

Cytocom has secured clearance from the US Food and Drug Administration (FDA) to undertake a phase 2 clinical trial of CYTO-205 for the treatment of Covid-19. The company’s investigational new drug (IND) application More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Sunday, February 28th, 2021
0 Comments

FDA authorizes emergency use of Janssen COVID-19 Vaccine

The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the Janssen COVID-19 Vaccine – Ad26.COV2.S manufactured by Johnson & Johnson subsidiary Janssen Biotech. It More...

By pharmanewsdaily On Saturday, January 23rd, 2021
0 Comments

UAE approves Russia-made Sputnik V Covid-19 vaccine

The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health and Prevention (MOHAP) in the country for providing protection More...

By pharmanewsdaily On Saturday, December 19th, 2020
0 Comments

US FDA authorizes Moderna Covid-19 vaccine mRNA-1273

Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine candidate of Moderna. The FDA authorization More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Thursday, November 26th, 2020
0 Comments

India approves Saragene COVID-19 2-gene multiplex RT-PCR test

CoSara Diagnostics has secured clearance from the Indian Central Drugs Standard Control Organization (CDSCO) to manufacture and sell its Saragene COVID-19 2-gene multiplex RT-PCR test. The approval allows the Saragene More...

By pharmanewsdaily On Friday, October 16th, 2020
0 Comments

Oxford develops rapid diagnostic test to detect Covid-19 within 5mins

Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and identify viruses within five minutes, More...

By pharmanewsdaily On Monday, July 20th, 2020
0 Comments

COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine (AZD1222) to be well tolerated besides generating More...